Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is a 200% increase over the number of companies inspected in the previous month, when one company received one inspection.
The companies inspected were involved in the Biologics sector.
All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| American Red Cross | Biologics | 03/18/2024 | No Action Indicated (NAI) |
| UNC Healthcare/Fertility | Biologics | 03/19/2024 | No Action Indicated (NAI) |
| Veterans Administration Medical Center Laboratory Service | Biologics | 03/20/2024 | No Action Indicated (NAI) |
Alerts Sign-up